(Q24201100)

ORCID Public Data File 2021

author name string

Nianfang Hu

series ordinal

3

0 references

publication date

14 March 2012

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

Oral agents in the management of urticaria: patient perception of effectiveness and level of satisfaction with treatment.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Histamine antagonists in the treatment of acute allergic reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Famotidine in the treatment of acute urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Cimetidine in chronic idiopathic urticaria: a randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Comparison of cimetidine and diphenhydramine in the treatment of acute urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

In dermographic urticaria H2 receptor antagonists have a small but therapeutically irrelevant additional effect compared with H1 antagonists alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Helicobacter pylori infection in patients with chronic urticaria: correlation with pathologic findings in gastric biopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Guidelines for evaluation and management of urticaria in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Increasing hospital admissions for systemic allergic disorders in England: analysis of national admissions data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Clinical practice. Chronic urticaria and angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Pathogenesis of chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Chronic urticaria: aetiology, management and current and future treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Human skin mast cells express H2 and H4, but not H3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Histamine-2 receptor antagonists as immunomodulators: new therapeutic views?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Chronic urticaria: the autoimmune paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

BSACI guidelines for the management of chronic urticaria and angio-oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the Grading of Recommendations Assessment, Development, and Evaluation system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

H1-antihistamines for chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008596.PUB2

Antihistamines in the treatment of chronic urticaria.

21 January 2018

1 reference

12 December 2020

The effect of H1 and H2 histamine antagonists on symptomatic dermographism

1 reference

12 December 2020

Effectiveness of combination treatment with H1-(Tavegyl) and H2-antagonists (Altramet) in chronic/chronically-recurrent urticaria

1 reference

12 December 2020

Quality of life in patients with urticaria

1 reference

12 December 2020

Epidemiology, healthcare, resources, use and clinical features of different types of urticaria. Alergológica 2005.

1 reference

12 December 2020

Management of idiopathic urticaria with H1 + H2 antagonists. A crossover double blind long-term study

1 reference

12 December 2020

Lack of effect of H2 blockade in chronic urticaria [proceedings]

1 reference

12 December 2020

Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists

1 reference

12 December 2020

Assessing the treatment of solar urticaria. The dose-response as a quantifying approach

1 reference

12 December 2020

Histamine receptors in human skin: indirect evidence

1 reference

12 December 2020

Factitious urticaria (dermographism): treatment by cimetidine and chlorpheniramine in a randomized double-blind study

1 reference

12 December 2020

[Therapy of urticaria with H1 and H2 antihistaminics. Results of clinical and experimental studies]

1 reference

12 December 2020

Allergists and dermatologists have far more expertise in caring for patients with urticaria than other specialists

1 reference

12 December 2020

Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria

1 reference

12 December 2020

1 reference

12 December 2020

Lack of effect of cimetidine in chronic-idiopathic urticaria

1 reference

12 December 2020

Urticaria and angioedema

1 reference

12 December 2020

Acute urticaria: etiologies, clinical course and quality of life.

1 reference

12 December 2020

Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patients

1 reference

12 December 2020

The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria

1 reference

12 December 2020

A controlled trial of therapy in chronic urticaria

1 reference

12 December 2020

Histamine H2-receptor antagonists

1 reference

12 December 2020